Hospice News February 27, 2025
Amedisys Inc. (Nasdaq: AMED) saw hospice revenue growth during the fourth quarter of 2024 despite merger-related costs associated with its pending acquisition by UnitedHealth Group (NYSE: UNH).
The company’s hospice business saw net service revenues of $212.9 million during the fourth quarter of 2024, up from $20.6 million year over year. For the full year 2024, net service revenue reached $825.8 million, an increase from $798 million in 2023.
“Our focus is on building and retaining an exceptional team, delivering the highest quality care and service to our patients and their families and establishing Amedisys as the preferred and preeminent hospice provider in each community we serve,” Amedisys indicated in a U.S. Securities & Exchange Commission filing. “In order to...
Today's Sponsors
Today's Sponsor